CORMORANT ASSET MANAGEMENT, LP enters AMBRX BIOPHARMA CAYMAN, INC. with 52.50M shares across direct and indirect positions
This filing by CORMORANT ASSET MANAGEMENT, LP establishes the baseline for all future Form 4 insider transaction reports at AMBRX BIOPHARMA CAYMAN, INC..
Indirect
Filed: 3/13/2023ACC: 0000929638-23-000831
10% Owner
Since Mar 2023
52.50M
Baseline shares
0.00
Direct ownership
0 positions
0.00
Derivative underlying
0 instruments
1
Security positions
52.50M indirect
Non-Derivative Holdings1
Ordinary Shares
IndirectShares owned52.50M
Total
52.50M indirect52.50M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 52.50M | Indirect |
| Total | 52.50M | 52.50M indirect |
Derivative Holdings0
No derivative holdings reported